This immune response includes superantigen-like activation of T-cells with expansion of polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T-cells, something which is not seen in toxic shock syndrome, Kawasaki disease or COVID-19 in general. Here, CD8A is linked to COVID-19.